← Back to Vaccine Database

rVSV + IL-12 pDNA adjuvant

Live attenuated vaccine · VDDBV0666

Target & Classification

HIVHuman immunodeficiency virus
Live attenuated vaccine
HIV Infections
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT01859325 Phase 1HIV Infections